Deutsche Bank analyst George Hill maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $5 to $4.
Deutsche Bank Maintains Hold on Agilon Health, Lowers Price Target to $4
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.